- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 40/00 - Cellular immunotherapy
Patent holdings for IPC class A61K 40/00
Total number of patents in this class: 26
10-year publication summary
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
18
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Mdx Management LLC | 13 |
3 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 2934 |
2 |
| Dispatch Biotherapeutics, Inc. | 6 |
2 |
| Merck Patent GmbH | 5770 |
1 |
| Centre National de La Recherche Scientifique | 10611 |
1 |
| Assistance Publique - Hopitaux de Paris | 1023 |
1 |
| Autolus Limited | 257 |
1 |
| Consejo Superior de Investigaciones Cientificas (csic) | 1384 |
1 |
| Fondazione IRCCS Istituto Nazionale Dei Tumori | 49 |
1 |
| Institut Curie | 600 |
1 |
| Medigene Immunotherapies GmbH | 75 |
1 |
| Sun Yat-sen University | 689 |
1 |
| Zhejiang University | 3220 |
1 |
| BeiGene Switzerland GmbH | 172 |
1 |
| Université Paris-saclay | 560 |
1 |
| Université Paris Cité | 826 |
1 |
| Kelonia Therapeutics, Inc. | 42 |
1 |
| FibroBiologics | 6 |
1 |
| Curevac SE | 269 |
1 |
| Akamis Bio Limited | 54 |
1 |
| Other owners | 2 |